Published March 2017 | Version v1
Journal article Metadata-only

The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis

Creators

  • 1. University of Genoa and IRCCS AOU San Martino-IST, Nuclear Medicine, Department of Health Science (DISSAL), Genoa (Italy)
  • 2. University of Navarra, Department of Nuclear Medicine, Clinica Universidad de Navarra, Pamplona (Spain)
  • 3. University of Amsterdam, Department of Nuclear Medicine, Academic Medical Center, Amsterdam (Netherlands)
  • 4. Yale University School of Medicine, Radiology and Biomedical Imaging, New Haven, CT (United States)
  • 5. CHU de Caen, U1077, Caen (France)
  • 6. Ecole Pratique des Hautes Etudes, UMR-S1077, Caen (France)
  • 7. Universite de Caen Basse-Normandie, UMR-S1077, Caen (France)
  • 8. Inserm, U1077, Caen (France)
  • 9. University of Utah, Department of Radiology and Imaging Sciences, Salt Lake City, UT (United States)
  • 10. QMC-Quality Medical Consulting, Hamden, Michigan (United States)
  • 11. University of Michigan Ann Arbor, Hamden, Michigan (United States)
  • 12. University of Cologne, Department of Nuclear Medicine, Cologne (Germany)
  • 13. Bagcilar Education and Research Hospital, Department of Nuclear Medicine, Istanbul (Turkey)
  • 14. Geneva University and Geneva University Hospitals, Department of Medical Imaging, Geneva (Switzerland)
  • 15. University of Leipzig, Department of Nuclear Medicine, Leipzig (Germany)
  • 16. Kindai University, Department of Radiology, Faculty of Medicines, Osaka (Japan)
  • 17. Veterans Affairs Healthcare System, Department of Radiology, Greater Los Angeles, CA (United States)
  • 18. VU University Medical Center, Department of Radiology and Nuclear Medicine, Amsterdam (Netherlands)
  • 19. Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen (Denmark)
  • 20. University of Texas Southwestern Medical Center, Department of Radiology, Dallas, TX (United States)
  • 21. Hospital das Forcas Armadas, Departament of Nuclear Medicine, Brasilia (Brazil)
  • 22. Karolinska Hospital, Department of Nuclear Medicine, Stockholm (Sweden)
  • 23. Institute of Cognitive Sciences and Technologies, CNR, Rome (Italy)
  • 24. Institute of Biostructure and Bioimaging, CNR, Naples (Italy)
  • 25. University of California, Department of Molecular and Medical Pharmacology, Los Angeles, CA (United States)
  • 26. ''Sapienza'' University of Rome, Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Rome (Italy)
  • 27. University of Melbourne, Florey Institute of Neuroscience and Mental Health, Melbourne (Australia)
  • 28. University of Melbourne, Department of Medicine, Melbourne (Australia)
  • 29. Austin Health, Department of Molecular Imaging, Melbourne (Australia)

Description

no abstract available

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00259-016-3589-9

Additional details

Identifiers

DOI
10.1007/s00259-016-3589-9;

Publishing Information

Journal Title
European Journal of Nuclear Medicine and Molecular Imaging
Journal Volume
44
Journal Issue
3
Journal Page Range
p. 353-357
ISSN
1619-7070

INIS

Country of Publication
Germany
Country of Input or Organization
Germany
INIS RN
48037851
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
No Abstract
Descriptors DEI
BRAIN; CLINICAL TRIALS; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC USES; ENCEPHALITIS; FLUORINE 18; FLUORODEOXYGLUCOSE; INFECTIOUS DISEASES; INFLAMMATION; METABOLISM; POSITRON COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; STANDARDIZATION; UPTAKE
Descriptors DEC
ANTIMETABOLITES; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; CENTRAL NERVOUS SYSTEM; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; FLUORINE ISOTOPES; HOURS LIVING RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MATERIALS; NANOSECONDS LIVING RADIOISOTOPES; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; NUCLEI; ODD-ODD NUCLEI; ORGANS; PATHOLOGICAL CHANGES; RADIOACTIVE MATERIALS; RADIOISOTOPES; SYMPTOMS; TESTING; TOMOGRAPHY; USES